|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0020268,
umls-concept:C0025677,
umls-concept:C0034897,
umls-concept:C0038952,
umls-concept:C0205527,
umls-concept:C0332161,
umls-concept:C0355642,
umls-concept:C0392756,
umls-concept:C0445202,
umls-concept:C0677582,
umls-concept:C0927232,
umls-concept:C1332225
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2002-9-4
|
|
pubmed:abstractText |
Central nervous system (CNS) recurrence is almost invariably fatal in patients with aggressive non-Hodgkin lymphoma (NHL). Although some protocols are intended to prevent CNS disease, the value of CNS prophylaxis in patients with aggressive NHL remains to be determined.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2002 American Cancer Society.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
95
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
576-80
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:12209750-Adolescent,
pubmed-meshheading:12209750-Adult,
pubmed-meshheading:12209750-Aged,
pubmed-meshheading:12209750-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12209750-Central Nervous System Neoplasms,
pubmed-meshheading:12209750-Female,
pubmed-meshheading:12209750-Follow-Up Studies,
pubmed-meshheading:12209750-Humans,
pubmed-meshheading:12209750-Hydrocortisone,
pubmed-meshheading:12209750-Injections, Spinal,
pubmed-meshheading:12209750-Lymphoma, Non-Hodgkin,
pubmed-meshheading:12209750-Male,
pubmed-meshheading:12209750-Methotrexate,
pubmed-meshheading:12209750-Middle Aged,
pubmed-meshheading:12209750-Neoplasm Recurrence, Local,
pubmed-meshheading:12209750-Remission Induction,
pubmed-meshheading:12209750-Retrospective Studies,
pubmed-meshheading:12209750-Survival Analysis,
pubmed-meshheading:12209750-Time Factors,
pubmed-meshheading:12209750-Treatment Outcome
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma.
|
|
pubmed:affiliation |
First Department of Internal Medicine, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-004, Japan. cavalier@ch-yamate.dienet.com
|
|
pubmed:publicationType |
Journal Article
|
